- Home
- CAN vs LFCR Comparison
CAN vs LFCR Comparison
Compare CAN & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAN
- LFCR
- Stock Information
- Founded
- CAN 2013
- LFCR 1986
- Country
- CAN Singapore
- LFCR United States
- Employees
- CAN N/A
- LFCR N/A
- Industry
- CAN Semiconductors
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- CAN Technology
- LFCR Health Care
- Exchange
- CAN Nasdaq
- LFCR Nasdaq
- Market Cap
- CAN 330.5M
- LFCR 308.8M
- IPO Year
- CAN 2019
- LFCR N/A
- Fundamental
- Price
- CAN $0.81
- LFCR $7.68
- Analyst Decision
- CAN Strong Buy
- LFCR Buy
- Analyst Count
- CAN 6
- LFCR 4
- Target Price
- CAN $2.50
- LFCR $8.00
- AVG Volume (30 Days)
- CAN 28.0M
- LFCR 124.7K
- Earning Date
- CAN 08-14-2025
- LFCR 10-03-2025
- Dividend Yield
- CAN N/A
- LFCR N/A
- EPS Growth
- CAN N/A
- LFCR N/A
- EPS
- CAN N/A
- LFCR N/A
- Revenue
- CAN $345,360,000.00
- LFCR $128,867,000.00
- Revenue This Year
- CAN $90.25
- LFCR $4.71
- Revenue Next Year
- CAN $42.94
- LFCR $10.98
- P/E Ratio
- CAN N/A
- LFCR N/A
- Revenue Growth
- CAN 82.40
- LFCR 0.47
- 52 Week Low
- CAN $0.53
- LFCR $4.33
- 52 Week High
- CAN $3.27
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- CAN 60.04
- LFCR 53.40
- Support Level
- CAN $0.68
- LFCR $7.00
- Resistance Level
- CAN $0.80
- LFCR $7.82
- Average True Range (ATR)
- CAN 0.04
- LFCR 0.41
- MACD
- CAN 0.01
- LFCR 0.01
- Stochastic Oscillator
- CAN 77.96
- LFCR 40.24
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.